European Communities – measures affecting the approval
and marketing of biotech products

STATUS REPORT BY THE EUROPEAN UNION

Addendum

The following communication, dated 8 July 2022, from the delegation of the European Union to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

_______________

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document WT/DS293/41) and Canada (WT/DS292/40), the European Union remains ready to continue its discussions with the United States with the goal of resolving this dispute and related issues.